Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Automated visual acuity estimation by optokinetic nystagmus using a stepped sweep stimulus

View ORCID ProfileJason Turuwhenua, Zaw LinTun, View ORCID ProfileMohammad Norouzifard, View ORCID ProfileMisty Edmonds, View ORCID ProfileRebecca Findlay, View ORCID ProfileJoanna Black, Benjamin Thompson
doi: https://doi.org/10.1101/2024.02.19.23300472
Jason Turuwhenua
1Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand
2School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jason Turuwhenua
  • For correspondence: j.turuwhenua{at}auckland.ac.nz
Zaw LinTun
1Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Norouzifard
1Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohammad Norouzifard
Misty Edmonds
4Iwi United Engaged Ltd, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Misty Edmonds
Rebecca Findlay
2School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca Findlay
Joanna Black
2School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joanna Black
Benjamin Thompson
2School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand
3School of Optometry and Vision Science, The University of Waterloo, Ontario, Canada
5Centre for Eye and Vision Research, 17W Science Park, Hong Kong
6Liggins Institute, The University of Auckland, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Purpose Measuring visual acuity (VA) can be challenging in adults with cognitive impairment and young children. We developed an automatic system for measuring VA using Optokinetic Nystagmus (OKN).

Methods VA-OKN and VA by ETDRS (VA-ETDRS) were measured monocularly in healthy participants (n=23, age 30±12). VA was classified as reduced (n=22, >0.2 logMAR) or not (n=24, ≤0.2 logMAR) in each eye. VA-OKN stimulus was an array of drifting (5 deg/sec) vanishing disks presented in descending/ascending size order (0.0 to 1.0 logMAR in 0.1 logMAR steps). The stimulus was stepped every 2 seconds, and 10 sweeps were shown per eye. Eye tracking data determined when OKN activity ceased (descending sweep) or began (ascending sweep) to give an automated sweep VA. Sweep traces were randomized and assessed by a reviewer blinded to VA-ETDRS. A final per sweep VA and VA-OKN was thereby determined.

Results A single randomly selected eye was used for analysis. VA deficit group: There was no significant difference between overall mean VA-OKN and VA-ETDRS (p>0.05, paired t-test) and the r2 statistic was 0.84. The 95% limits of agreement were 0.19 logMAR. No VA deficit group: There was a 0.24 logMAR bias between VA-OKN and VA-ETDRS and no correlation was found (r2 = 0.06). However, the overall sensitivity/specificity for classification was 100%.

Conclusions A robust correlation between VA-ETDRS and VA-OKN was found. The method correctly detected a VA deficit.

Translational relevance OKN is a promising method for measuring VA in cognitively impaired adults and pre-verbal children.

INTRODUCTION

Visual acuity (VA) is the quantitative measure of the ability to discriminate fine detail. It is arguably the single-most important functional measure of vision, and it is used to diagnose and monitor a range of visual disorders including refractive error, macular degeneration and amblyopia.1, 2 However, measuring VA is challenging in people who may lack the cognitive ability to perform standard VA tests, such as adults with neurological impairment or very young children.3, 4

There are two objective approaches available to estimate VA in such patients: 1) visual evoked potentials (VEPs) or 2) optokinetic nystagmus (OKN).5 VEPs are electrical responses measured from the visual cortex that arise in response to structured targets shown to the observer. The stimulus is typically constructed from stripes, gratings or checkboards, which are typically swept in steps from low to high frequency with cortical activity measured at each step. VA is determined by regression applied to higher spatial frequency activities in order to find the x-axis crossing of the activity versus time graph,6 the idea being that cortical activity decreases as the stimulus’ spatial frequency approaches threshold. However, despite the fact that the sweep VEP is a rapid and well understood method7, 8 in clinical practice it requires a trained operator and expensive/complex equipment which makes it difficult to implement.5, 9

OKN is a reflexive oculomotor response of the eye consisting of stereotyped slow tracking (the slow phase or SP) and quick, opposite direction, re-fixation movements (the quick phase or QP) that occur in response to a drifting pattern.10 OKN manifests as a highly distinctive “beating” of the eye, which appears in eye tracking data as a repeated “sawtooth” pattern on a displacement versus time plot as shown in Fig.1. In clinical practice, OKN is elicited by the induction method: a vertically striped drum is rotated in front of the patient. If the stimulus is visible to the observer it will elicit the involuntary OKN response whilst if it is invisible to the patient then it will not. Varying the spatial frequency of the stimulus (by altering the distance of the drum to the eye), gives an estimate of VA as the minimum grating size that elicited OKN. However, the spinning drum technique is a highly subjective procedure.

FIGURE 1.
  • Download figure
  • Open in new tab
FIGURE 1.

Optokinetic nystagmus. Automatically detected slow phases are shown in green, and quick phases are shown in red.

The general concept of objective estimation of VA using OKN is long established,11–13 yet its application as an objective probe of visual function is only now receiving renewed interest.14–19 Hyon et. al. incorporated video-oculography and used a high contrast (85%) striped stimulus drifting at 10 deg/sec on a display to test distance vision.20 The induction method was used to measure a minimum stripe size. The suppression method,5 in which a fixation target of varying visibility is used to halt the response, was also used to determine the minimum dot size needed to stop the optokinetic response. In that work, r2 statistics of 0.57 and 0.83 were reported against logMAR VA using induction/suppression paradigms respectively. Shin et al. 21 used a similar experimental paradigm applied to a range of disease states. The reported correlation coefficients corresponded to r2 statistics between 0.38-0.88 (induction) and 0.006-0.76 (suppression). However, Aleci et al. noted that the precision and accuracy in these previous studies was low,14, 22 and that the stripe stimulus velocity imposed severe restrictions on the range of acuities that could be tested. Aleci et al. therefore proposed a slowly moving (1.43 and 2.86 deg/sec) and low contrast (20%) row of optotypes. Using an induction paradigm an r2 statistic of 0.74 with VA (measured by Sloan optotypes) was reported for co-operative participants, noting also the inclusion of a noise component added to the symbols to lower the visibility of larger optotypes. Using the same paradigm, Aleci et. al 22 subsequently reported r2 statistics of 0.63 and 0.70 with subjective VA for AMD and Cataract patients respectively.

Our own approach shares a similar motivation to that of Aleci et al. Firstly, we avoid a striped stimulus. Instead we propose a novel stimulus consisting of an array of slow drifting (5 deg/sec) vanishing disk optotypes. As shown in Fig. 2(a), each disk of the array comprises a brighter central disk (mean contrast 87%) which determines the angular size of the stimulus calibrated in logMAR units. Crucially, the disk has a darker surround (mean contrast −14%) that averages out the central disk at threshold in accordance with the vanishing principle.23, 24 In doing so, we aim to mitigate the velocity and width restrictions imposed by stripes, avoid very low contrast (20%) stimuli that have been used previously, and remove the need for additional noise. Moreover, an advantage of the logMAR specification is that it avoids reliance on arbitrary units used previously.11, 20–22

FIGURE 2.
  • Download figure
  • Open in new tab
FIGURE 2.

(a) The VA for the vanishing disk stimulus is determined by the angular size (α) of the central brighter disk. (b) The stimulus is a horizontally drifting array of vanishing disks, which is swept in descending/ascending order. (c) Analysis of eye tracking data. Top panel shows results for a descending sweep whilst bottom panel shows results for an ascending sweep. The OKN activity is shown in orange along the bottom. The OKN drop-off point/onset point determines a VA for a sweep. (d) Final VA-OKN is the average of a total of 10 sweeps.

In this work we use repeating stepped ascending and descending sweeps varying the logMAR size of the stimulus at each step as shown in Fig. 2(b). Aleci et al. used a similar adaptive sweep that was subjectively driven by an observer. However we use eye tracking to objectively measure eye displacement data during each sweep, which is processed by an OKN detection system. Fig. 2(c) shows eye tracker data for a descending (top panel) and ascending sweep (lower panel). The figure shows OKN activity for the sweep (shown in orange) which is used to determine the OKN drop-off and onset times (the times when OKN stops or starts depending on sweep direction). For a given descending sweep the drop-off point is the last time point of OKN activity, whilst for the ascending sweep the onset time point is the first point of OKN activity. Finally we perform VA scoring as shown in Fig. 2(d). We propose a per sweep VA based on standard letter-by-letter scoring used for VA charts.25 Our key modification is to replace letter counting with the drop-off/onset times at which OKN disappears/appears to provide a VA. An overall final VA is found by averaging over all sweeps.

We provide proof-of-concept of the overall approach in a small cohort of people with and without a visual deficit. We determine a VA by automation, and then obtain a final VA-OKN after assessment by a reviewer blinded to VA by ETDRS (VA-ETDRS). Final VA-OKN is compared to VA-ETDRS measured using the Electronic Visual Acuity (EVA) tester (Emmes, USA). Potential improvements to the presented work are provided in the discussion.

DESCRIPTION OF PROCESSING PIPELINE

VA scoring for OKN

Our scoring is based on the Early Treatment of Diabetic Retinopathy Study (ETDRS) chart. The chart consists of 5 letters per line. Each line differs by 0.1 logMAR, and each letter has a value of 0.02 logMAR. In a standard letter-by-letter scoring method25 the patient reads out aloud each letter from the largest logMAR line (VAmax) to the smallest (VAmin). VA↓ is then given by, Embedded Image where n is the number of correctly identified letters, and the arrow indicates the direction of reading (from largest to smallest letters). It is also possible to move from the smallest letters of size VAmin to the largest. In this case we have, Embedded Image where m is now the number of incorrectly counted letters, and the up arrow indicates the direction of reading (from smallest to largest letters).

Crucially, our approach proposes to replace letters in Eqns. (1) and (2) by the time at which the OKN response to stimulus of decreasing/increasing size either stops, t↓ or commences t↑ (descending and ascending sweeps respectively). Eqn (1) now becomes Embedded Image for the descending sweep, and Eqn. (2) becomes Embedded Image for the ascending sweep. Here k is the absolute step-rate in logMAR/sec. It is noted here that using the earliest/latest time to replace letter counting is a convenient heuristic that we test empirically. The methods for determining t↓ and t↑ that we implemented will be described further below.

If a sweep did not generate detectable OKN then the VA was set to the upper limit VAmax +0.1 on the understanding that it would be greater than or equal to this result. This could be expected if a participant did not see the stimulus, or did not generate detectable OKN during the test, or if there was an OKN detection/measurement failure.

OKN detection

Objective OKN detection was facilitated, in this work, by an already published method. The reader is encouraged to consult that work for further details.26 In brief, this approach segmented the signal in the incoming eye tracking signal into SP-QP pairs. The SP was found by looking for a ramping displacement in the known stimulus direction. The QP was then found as a quick re-setting in the opposite direction subsequent to the SP. Candidate OKN was thresholded based on criteria such as amplitude, duration and velocity26 to eliminate unlikely detections. At this point, if remaining OKN was found to be repeating (2 or more consecutive detections) it was considered to be valid OKN. The “repeating OKN” criterion has proven to be a strong feature in work to date and also appears in the work of others.18, 26, 27 We also detected groups of at least three unconnected instances of OKN that fell within a sliding 2-second window. We observed that this situation could arise if OKN was present but was missed by the detector (e.g., low amplitude OKN). This “intermittent” OKN rule was used to mitigate cases where the “repeating OKN” criterion was not activated. Any OKN points found by these criteria were labelled as valid OKN.

OKN activity & VA estimation

The two empirical criteria of the previous section together give an instantaneous OKN activity, Embedded Image where the arrows specify an descending or ascending sweep respectively. Given a descending sweep, we define the OKN drop-off point t↓ as the point at which OKN ceases. More formally this is Embedded Image which is the maximum time point t↓ of OKN activity. If no drop-off time is found then VA↓ ≥ 0.1 + VAmax as determined by substituting t↓=0 in Eqn (3). Given an ascending sweep, the OKN onset time t↑ occurs at the minimum time of OKN activity, Embedded Image If this point does not exist then we set t↑ to the time corresponding to the end of the last presentation, and VA will also be VA↑ ≥ 0.1 + VAmax. In any case, given any otherwise found t↑ or t↓ value, we enter the result of Eqn. (5) into Eqn. (3) for VA↓, or Eqn. (6) into Eqn (4) for VA↑.

Fig 2(c) demonstrates this process in the case of two subsequent sweeps (descending/ascending respectively). The green/red regions indicate all instances of potential OKN. Our process identifies these as valid OKN (or not) to yield the OKN activity. The OKN activity is shown in orange along the base of each sweep (presence corresponds to activity). The drop-off and onset-points are the times of last activity (top panel) and first activity (bottom panel) respectively as marked as dotted lines. These are then transformed into logMAR VAs using Eqns. (3) and (4), and are reported in the top right corner of each panel.

METHODS

Participants

The research followed the tenets of the Declaration of Helsinki. The study was approved by the University of Auckland Human Participants Ethics Committee (UAHPEC20318). Participants (n=11) with reduced VA due to refractive error were recruited, as were participants with no refractive error (n=12). Both eyes of the participants were measured monocularly without refractive correction with occlusion of the non-tested eye.

VA-ETDRS

Participants’ VAs were measured using the EVA system in single-letter presentation mode. Letters were flanked by crowding bars. Testing distance was 3m. VA-ETDRS was the average of up to 5 repeated measurements taken consecutively within a single measurement session. Participants with a logMAR VA-ETDRS of ≤0.2 logMAR were classified as “no VA deficit”. Those with a VA of >0.2 logMAR were classified as belonging to a “reduced VA” group.29 These groups were analysed separately.

VA-OKN

Equipment

The viewing distance was 3 meters. The stimulus was presented on a 27-inch monitor (Dell S2716DG). This monitor had the nVidia Ultra-Low Motion Blur (ULMB) function engaged to minimize the presence of motion blur inherent to light-emitting diode displays.28 The refresh rate was 85 Hz. Eye tracking data was measured using Pupil Invisible glasses (Pupil Labs, Berlin, Germany) with sampling at 200Hz and down-sampling to 50Hz. The stimulus was written using the jsPsych framework for behavioural experiments, and the experiment was presented using the Chrome web-browser window running in full-screen mode. The system was co-ordinated by a standard desktop PC using a combination of Javascript and Python. Further offline analysis of this data after data collection was performed using Matlab (Natick, VA).

Stepped sweep stimulus

The average contrast (with respect to the background) was 87% (central disk) and −14% (annulus). The angular size of the central disk was the central disk size in logMAR units. A sweep stepped through 11 logMAR levels from 0.0 to 1.0 in 0.1 logMAR steps in descending/ascending order. The stimulus stepped every 2 seconds (step rate was 0.05 logMAR/sec) and stimulus drift speed was 5 deg/sec for the entirety of a sweep. The total presentation time for a single sweep was 22 seconds. The first/last presentations were extended before the start and end of the measurement interval by 0.75 sec (giving a total presentation time of 23.5 seconds) to allow some time for OKN to either initiate before or pass beyond the analysis interval. These appear as the blue regions on either side of a sweep presented in Fig 2(b) and were not included for analysis. As mentioned already, the stimulus was shown as 5 descending/ascending interleaved sweeps (a total of 10 sweeps). The time to test an eye was about 4 minutes.

VA estimation

An automated per sweep VA (VA↑ or VA↓) was determined using the objective analysis described in the previous section. OKN detection was performed using a single “best set” of OKN detection parameters that were found empirically and applied across all data collected.

The total number of sweeps processed was 460 (23 participants * 10 sweeps* 2 eyes = 460). Automated VA-OKN was averaged over the 10 sweeps per eye. Sweep data was reviewed at the time of data-collection. Measurement of an eye could be repeated if unwanted artefacts (e.g., due to excessive blinking, or noisy signal) were identified.

After this stage of analysis, a further assessment step was performed by a reviewer blinded to VA-ETDRS. Measured sweeps were randomized and resulting sweep data traces (for example as shown in Fig 2(c)) were provided to the reviewer. The reviewer was asked to identify their own estimate of a final per sweep VA starting with the automated sweep results. The average of these reviewed sweep VAs provided a final VA-OKN.

RESULTS

Results for final VA-OKN

A summary of results is presented in Table 1 and Table 2 for the “reduced VA” group and “no VA deficit” groups respectively (n=23 participants and a total of 46 eyes). Results below are reported for a randomly selected eye, noting that the right eyes for P-02 and P-04 were purposefully excluded from analysis because their final VA-OKN results were unbounded.

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1. VA-ETDRS and VA-OKN for the reduced VA cohort. Data is shown for both eyes, but only a randomly selected eye was used for reported comparisons (indicated by a tick).
View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 2. VA-ETDRS and VA-OKN for the no VA deficit cohort. Data is shown for both eyes, but only a randomly selected eye was used for reported comparisons (indicated by a tick).

Reduced VA group

VA-OKN was 0.52±0.37 logMAR (mean ± 2SD). VA-ETDRS was 0.54±0.45 logMAR. There was no significant difference between the two measures (p=0.55 >0.05, t=-0.61, paired t-test). Fig 3(a) presents a scatter plot comparing VA-OKN and VA-ETDRS for the “deficit” group only. The r-squared value (r2) was 0.84. The corresponding Bland-Altman diagram in Fig 3(b) plots the differences between VA-OKN and VA-ETDRS against their means. The limits of agreement (LoA) were 0.19 logMAR and the mean difference was −0.02 logMAR. The mean difference was not significantly different from zero by the result comparing VA-OKN and VA-ETDRS above.

FIGURE 3.
  • Download figure
  • Open in new tab
FIGURE 3.

(a) The correlation plot for the reduced VA group. The regression line is a solid line, the ideal line is dotted. (b) Bland-Altman diagram shows difference between VA-OKN and VA-ETDRS against their means.

No VA deficit group

VA-OKN was 0.05 ± 0.10 logMAR. VA-ETDRS was −0.19 ± 0.13 logMAR. There was a significant difference between the two groups (p=0.00 <0.05, t=8.50, paired t- test). This value was also lower/better than the floor of the OKN measurement device (0.0 to 1.1 logMAR). Fig 4(a) presents a scatter plot that directly compares VA-ETDRS and VA-OKN directly against each other for the “no deficit” group. The r2 statistic was 0.06 indicating no correlation between the two VA measures. The Bland-Altman diagram in Fig 4(b) produced an LoA of 0.14 logMAR and mean difference of 0.24 logMAR. The mean difference was significant as already determined by the result comparing VA-OKN to VA-ETDRS.

FIGURE 4.
  • Download figure
  • Open in new tab
FIGURE 4.

(a) The correlation plot for the no VA deficit group. The regression line is a solid line, the ideal line is dotted. Red line shows the floor of the OKN device (0.0 logMAR). (b) Bland-Altman diagram shows difference between VA-OKN and VA-ETDRS against their means.

Screening performance

There were no instances in which VA-OKN misclassified the presence/absence of VA deficit as determined by VA-ETDRS. Overall the sensitivity/specificity for detecting a VA deficit was 100%.

The effect of an expert review of automated VA-OKN

Reduced VA group

The overall mean for the deficit group found by automation was 0.54 ± 0.36 logMAR. This was not changed significantly by an expert review of the results (p=0.80>0.05, t=3.67, paired t-test). The r2 for final VA-OKN vs VA-ETDRS was 0.02 higher than the automated result alone. The LoA for final VA-OKN vs VA-ETDRS was 0.1 logMAR lower than the automated result.

No VA deficit group

The no VA deficit group mean was 0.07±0.10 logMAR by automation. The automated VA-OKN result was not changed significantly by the manual review (p=0.21>0.05, t=-1.32, paired t-test). The r2 and LoAs were unchanged.

Screening performance

The pre-review sensitivity was 92%. The specificity was 100%. The reduced sensitivity occurred because a single eye was incorrectly classified as having VA deficit (VA-OKN=0.21>0.2 logMAR) by automation.

DISCUSSION

In this paper we presented an automated pipeline for measurement of VA by OKN. The final VA-OKN results were encouraging. For those in the “VA deficit” group, for which the range of VA-ETDRS results fell within the measurement range of the VA-OKN measurement system, we observed a strong correlation (r2=0.84) between VA-OKN and VA-ETDRS. This r2 value compares favourably to results reported previously for VA by OKN between 0.53-0.83.14, 22, 30

Previous work has been somewhat limited by the use of arbitrary units,11, 14, 20, 21 which have constrained comparisons between OKN-induction stimuli spatial characteristics and standard letter based VA. In this work, Bland-Altman analysis indicated a degree of agreement between VA-OKN and VA-ETDRS. The LoAs for the VA deficit group were 0.19 logMAR. These limits are comparable to results from VEP based VA assessment noting two studies by Bach et. al. 7, 31 which indicated an accuracy of about 0.3 logMAR. Although not a direct comparison, the results are on the order of the inherent (test-retest) variability found for ETDRS charts of 0.11 to 0.25.29, 32 Whilst the present results are encouraging, we also recognize as with VEP,33 that OKN based testing is not the same as recognition VA measured with a chart. The exploration of these differences in healthy participants and those with ocular disease would characterize the method more fully and would be the subject of further work.

For the “no VA deficit” group we found a significant bias of 0.24 logMAR between VA-OKN and VA-ETDRS. VA-ETDRS was significantly better/lower than VA-OKN. Whilst the lowest/best VA-OKN that could be measured by our device was 0.0 logMAR, it is likely that there was also an inherent bias due to the stimulus itself. Hamilton et. al.8 reported similar biases between sweep VEP and recognition VA of 0.03 to 0.3 log units for normally sighted participants.

Extending the range of the stimulus to provide direct comparison in the lower/better logMAR range is a possibility for future work. A larger cohort with a wider spread of VA-ETDRS values should provide a clearer picture of performance overall.

VA-OKN accurately classified all participants as “no VA deficit” or “reduced VA” using a screening threshold of 0.2 logMAR. This result suggests that VA-OKN may provide a viable screening option, particularly for adults and children who are unable to engage with current vision screening techniques, which frequently involve measurement of visual acuity using symbols or letters.

It should be noted that the automated pipeline did require operator supervision. The expert review detected a misclassification error, and improved r2 and LoA overall. We observed that OKN detection could fail because of excessive blinking, false detections caused by noisy signal or incorrect classification of saccades as OKN; none of which were handled directly by the present method. Fortunately, we had the opportunity to address such issues by re-measuring our co-operative adult participants. Our system was not tested on adults with cognitive impairment or young children in this work, and we recognize that the opportunity to remediate measurement problems may not be available to the operator in such subjects. Improvements could be made to defend against unwanted artefacts (e.g., by pausing the experiment in the presence of excessive blinking), or to improve the robustness of data acquisition/analysis (e.g., by explicit detection and removal of purely saccadic movements). It may be that we could skip a given logMAR level if it was robustly detected (descending sweep) or, simply stop the sweep altogether similarly (ascending sweep) when OKN commenced. Recently, work has been done in improving the classification of OKN by machine learning methods35, 36 which we expect will have significant benefits for such efforts described here. For now, we can only emphasize the need for supervision and caution when interpreting results produced by the system.

Finally, we note that the parameters of the sweep such as stimulus velocity, step duration, and specific contrasts used in the construction of the stimulus were chosen largely empirically. Although the resulting stimulus presented here appeared to be effective, there remains a large parameter space for the OKN induction stimulus, and the optimum combination of spatial and temporal parameters is still being established.

CONCLUSION

We have presented a clinically inspired method for determining VA threshold using an automated response. The results support the concept of objective assessment of VA using OKN. Overall, the method here aims to progress toward clinically applicable objective estimation of VA using the optokinetic response. Results to date are encouraging, but further investigation into OKN based VA is warranted.

A simplified demonstration of the sweeping vanishing disk stimulus is available at: bit.ly/4ayJhwq

Data Availability

All data produced in the present work are contained in the manuscript

ACKNOWLEDGEMENT

Support is acknowledged from the Health Research Council of New Zealand (HRC21/514).

Footnotes

  • Financial support: Health Research Council of New Zealand (HRC 21/514). BT is supported by InnoHK and the Hong Kong Government.

  • Financial disclosures: The co-authors Turuwhenua and Thompson are co-inventors of the stimulus used in this work (Patent No. 11207023).

REFERENCES

  1. 1.↵
    Ariyasu, R. G. et al. Sensitivity, Specificity, and Predictive Values of Screening Tests for Eye Conditions in a Clinic-based Population. Ophthalmology 103, 1751–1760 (1996).
    OpenUrl
  2. 2.↵
    Holmes, J. M. & Clarke, M. P. Amblyopia. Lancet Lond. Engl. 367, 1343–1351 (2006).
    OpenUrl
  3. 3.↵
    Hoyt, C. S. Objective techniques of visual acuity assessment in infancy. Aust. N. Z. J. Ophthalmol. 14, 205–209 (1986).
    OpenUrlPubMed
  4. 4.↵
    Anstice, N. S. & Thompson, B. The measurement of visual acuity in children: an evidence-based update. Clin. Exp. Optom. 97, 3–11 (2014).
    OpenUrlCrossRefPubMed
  5. 5.↵
    Aleci, C. & Rosa, C. Psychophysics in the ophthalmological practice—I. visual acuity. Ann. Eye Sci. 7, 37–37 (2022).
    OpenUrl
  6. 6.↵
    Almoqbel, F., Leat, S. J. & Irving, E. The technique, validity and clinical use of the sweep VEP. Ophthalmic Physiol. Opt. 28, 393–403 (2008).
    OpenUrlCrossRefPubMed
  7. 7.↵
    Bach, M., Link to external site, this link will open in a new tab & Farmer, J. D. Evaluation of the “Freiburg Acuity VEP” on Commercial Equipment. Doc. Ophthalmol. 140, 139–145 (2020).
    OpenUrl
  8. 8.↵
    Hamilton, R. et al. VEP estimation of visual acuity: a systematic review. Doc. Ophthalmol. Adv. Ophthalmol. 142, 25–74 (2021).
    OpenUrl
  9. 9.↵
    Schwob, N. & Palmowski-Wolfe, A. Objective measurement of visual acuity by optokinetic nystagmus suppression in children and adult patients. J. Am. Assoc. Pediatr. Ophthalmol. Strabismus 23, 272.e1–272.e6 (2019).
    OpenUrl
  10. 10.↵
    Waddington, J. & Harris, C. M. Human optokinetic nystagmus: A stochastic analysis. J. Vis. 12, 5–5 (2012).
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Reinecke, R. D. & Cogan, D. G. Standardization of Objective Visual Acuity Measurements: Opticokinetic Nystagmus us. Snellen Acuity. AMA Arch. Ophthalmol. 60, 418–421 (1958).
    OpenUrlPubMedWeb of Science
  12. 12.
    Lewkonia, I. Objective assessment of visual acuity by induction of optokinetic nystagmus. Br. J. Ophthalmol. 53, 641–644 (1969).
    OpenUrlFREE Full Text
  13. 13.↵
    Wester, S. T., Rizzo, J. F., Balkwill, M. D. & Wall, C. Optokinetic Nystagmus as a Measure of Visual Function in Severely Visually Impaired Patients. Invest. Ophthalmol. Vis. Sci. 48, 4542–4548 (2007).
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Aleci, C., Scaparrotti, M., Fulgori, S. & Canavese, L. A novel and cheap method to correlate subjective and objective visual acuity by using the optokinetic response. Int. Ophthalmol. (2017) doi:10.1007/s10792-017-0709-x.
    OpenUrlCrossRef
  15. 15.
    Dakin, S. C. & Turnbull, P. R. Similar contrast sensitivity functions measured using psychophysics and optokinetic nystagmus. Sci. Rep. 6, (2016).
  16. 16.
    Sangi, M. Automated Optokinetic Nystagmus Detection for Use with Young Subjects. (University of Auckland, 2017).
  17. 17.
    Ohnsman, C. M. et al. Pilot Study of Novel Optokinetic Nystagmus-Based Visual Acuity Test in Children with CLN2 Disease. Invest. Ophthalmol. Vis. Sci. 62, 3141 (2021).
    OpenUrl
  18. 18.↵
    Essig, P., Sauer, Y. & Wahl, S. Contrast Sensitivity Testing in Healthy and Blurred Vision Conditions Using a Novel Optokinetic Nystagmus Live-Detection Method. Transl. Vis. Sci. Technol. 10, 12 (2021).
  19. 19.↵
    Doustkouhi, S. M., Turnbull, P. R. K. & Dakin, S. C. The effect of refractive error on optokinetic nystagmus. Sci. Rep. 10, 20062 (2020).
    OpenUrl
  20. 20.↵
    Han, S. B. et al. Measurement of distance objective visual acuity with the computerized optokinetic nystagmus test in patients with ocular diseases. Graefes Arch. Clin. Exp. Ophthalmol. 249, 1379–1385 (2011).
    OpenUrlPubMed
  21. 21.↵
    Shin, Y. J. et al. Objective measurement of visual acuity by optokinetic response determination in patients with ocular diseases. Am. J. Ophthalmol. 141, 327–332 (2006).
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Aleci, C., Cossu, G., Belcastro, E. & Canavese, L. The optokinetic response is effective to assess objective visual acuity in patients with cataract and age-related macular degeneration. Int. Ophthalmol. (2018) doi:10.1007/s10792-018-1001-4.
    OpenUrlCrossRef
  23. 23.↵
    Shah, N., Dakin, S. C., Redmond, T. & Anderson, R. S. Vanishing optotype acuity: repeatability and effect of the number of alternatives. Ophthalmic Physiol. Opt. 31, 17–22 (2011).
    OpenUrlCrossRefPubMed
  24. 24.↵
    Frisén, L. Vanishing optotypes: new type of acuity test letters. Arch. Ophthalmol. 104, 1194–1198 (1986).
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    Vanden Bosch, M. E. & Wall, M. Visual acuity scored by the letter-by-letter or probit methods has lower retest variability than the line assignment method. Eye 11, 411–417 (1997).
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Norouzifard, M., Black, J., Thompson, B., Klette, R. & Turuwhenua, J. A Real-Time Eye Tracking Method for Detecting Optokinetic Nystagmus. in Pattern Recognition (eds. Palaiahnakote, S., Sanniti di Baja, G., Wang, L. & Yan, W. Q.) 143–155 (Springer International Publishing, 2020). doi:10.1007/978-3-030-41299-9_12.
    OpenUrlCrossRef
  27. 27.↵
    Turuwhenua, J., Yu, T. Y., Mazharullah, Z. & Thompson, B. A method for detecting optokinetic nystagmus based on the optic flow of the limbus. Vision Res. 103, 75–82 (2014).
    OpenUrl
  28. 28.↵
    Ito, H., Ogawa, M. & Sunaga, S. Evaluation of an organic light-emitting diode display for precise visual stimulation. J. Vis. 13, (2013).
  29. 29.↵
    Rosser, D. A., Cousens, S. N., Murdoch, I. E., Fitzke, F. W. & Laidlaw, D. A. H. How Sensitive to Clinical Change are ETDRS logMAR Visual Acuity Measurements? Invest. Ophthalmol. Vis. Sci. 44, 3278–3281 (2003).
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    Hyon, J. Y. et al. Objective measurement of distance visual acuity determined by computerized optokinetic nystagmus test. Invest. Ophthalmol. Vis. Sci. 51, 752–757 (2010).
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    Bach, M., Maurer, J. P. & Wolf, M. E. Visual evoked potential-based acuity assessment in normal vision, artificially degraded vision, and in patients. Br. J. Ophthalmol. 92, 396–403 (2008).
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    Siderov, J. & Tiu, A. L. Variability of measurements of visual acuity in a large eye clinic. Acta Ophthalmol. Scand. 77, 673–676 (1999).
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    Zheng, X. et al. Assessment of Human Visual Acuity Using Visual Evoked Potential: A Review. Sensors 20, 5542 (2020).
    OpenUrl
  34. 34.
    Beck, R. W. et al. A computerized method of visual acuity testing: Adaptation of the early treatment of diabetic retinopathy study testing protocol. Am. J. Ophthalmol. 135, 194–205 (2003).
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Newman, J. L., Phillips, J. S. & Cox, S. J. 1D Convolutional Neural Networks for Detecting Nystagmus. IEEE J. Biomed. Health Inform. 25, 1814–1823 (2021).
    OpenUrl
  36. 36.↵
    Ben Slama, A., et al. A deep convolutional neural network for automated vestibular disorder classification using VNG analysis. Comput. Methods Biomech. Biomed. Eng. Imaging Vis. 8, 334–342 (2020).
    OpenUrl
Back to top
PreviousNext
Posted February 20, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Automated visual acuity estimation by optokinetic nystagmus using a stepped sweep stimulus
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Automated visual acuity estimation by optokinetic nystagmus using a stepped sweep stimulus
Jason Turuwhenua, Zaw LinTun, Mohammad Norouzifard, Misty Edmonds, Rebecca Findlay, Joanna Black, Benjamin Thompson
medRxiv 2024.02.19.23300472; doi: https://doi.org/10.1101/2024.02.19.23300472
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Automated visual acuity estimation by optokinetic nystagmus using a stepped sweep stimulus
Jason Turuwhenua, Zaw LinTun, Mohammad Norouzifard, Misty Edmonds, Rebecca Findlay, Joanna Black, Benjamin Thompson
medRxiv 2024.02.19.23300472; doi: https://doi.org/10.1101/2024.02.19.23300472

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Primary Care Research
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)